Rv1221 - p.Gly219Asp
Drug resistance types
3 Sensitive
0 RR-TB
0 HR-TB
3 MDR-TB
0 Pre-XDR-TB
0 XDR-TB
1 Other
lineage Counts
| lineage | Count |
|---|---|
| lineage2.2 | 1 |
| La2;lineage2.2 | 1 |
| lineage1.1.2 | 3 |
| lineage4.9 | 1 |
| La2;lineage4.9 | 1 |
spoligotype Counts
| spoligotype | Count |
|---|---|
| None | 7 |
Geographic prevalence
Country level data for this variant is available for 0 isolates.
Variant Proportion
Hover over a Country 0–0.1
0.1–0.2
0.2–0.3
0.3–0.4
0.4–0.5
0.5–0.6
0.6–0.8
0.8+
0.1–0.2
0.2–0.3
0.3–0.4
0.4–0.5
0.5–0.6
0.6–0.8
0.8+
Statisctical support
Not enough data to calculate support.
Samples
| ID | Drug resistance | Lineage | Country iso2 |
|---|---|---|---|
| ERR4810624 | MDR-TB | lineage2.2 | None |
| ERR1063839 | MDR-TB | La2;lineage2.2 | None |
| ERR2517652 | Sensitive | lineage1.1.2 | nl |
| SRR3675387 | Other | lineage4.9 | None |
| ERR2446108 | Sensitive | lineage1.1.2 | nl |
| ERR3275617 | Sensitive | lineage1.1.2 | nl |
| ERR1063857 | MDR-TB | La2;lineage4.9 | None |
